Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823095 · ClinicalTrials.gov registry record · Phase 2
Topical Nitric Oxide Trial in Chronic Non-Healing Wounds
A Phase 2 study, sponsored by Loma Linda University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00823095: Clinical Trial Phase 2 study, sponsored by Loma Linda University.
NCT00823095 is a Phase 2 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823095, a Phase 2 study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.
Interventions
- DRUG Nitric Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Why NCT00823095 stopped before completion
NCT00823095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Nitric Oxide is the first listed.
NCT00823095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00823095 about?
NCT00823095 is a clinical study titled "Topical Nitric Oxide Trial in Chronic Non-Healing Wounds". To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.
What is the current status of trial NCT00823095?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2005-12. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00823095?
The interventions under investigation include: Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT00823095?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00823095's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia